Drug Trial Radar · NCT00595231
Exploratory Study to Evaluate the Effect of SYN111 (Rufinamide) in Patients With Generalized Anxiety Disorder (GAD)
Last checked: Nov 19, 2026Latest source record: Feb 27, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
239
Actual
Start
Mar 2008
Primary completion
Oct 2008
Study completion Oct 2008
Sponsor
- Lead sponsor
- Biotie Therapies Inc.Industry
- Sponsor type
- Industry
- Collaborators
- Syneos Health
- First posted
- Jan 16, 2008
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A Multi-Centered Randomized, Double-Blind, Placebo-Controlled, Phase 2, Exploratory Study to Evaluate the Effect of Rufinamide on Anxiety in Patients with Moderate to Severe Generalized Anxiety Disorder.
Conditions
- Generalized Anxiety Disorder
Interventions
SYN111Drug
500 mg for 1 week followed by 1000 mg for 7 weeks
PlaceboDrug
0 mg tablets
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline in Hamilton Anxiety Scale (HAMA) - Total Score: Summary Statistics - ObservedTime frame: 8 Weeks
- Change From Baseline in Hospital Anxiety and Depression Scale (HADS). Summary StatisticsTime frame: 8 Weeks
- Change From Baseline in Montgomery-Asberg Depression Scale (MADRS) Summary Statistics.Time frame: 8 Weeks
- Change From Baseline in Clinical Global Impression Scale for Severity of Illness: (CGI-S)Time frame: 8 weeks
- Change From Baseline Raskin Depression Scale.Time frame: 8 weeks
- Change From Baseline in Covi Anxiety Scale (CAS) - Index Total Score: Summary Statistics ObservedTime frame: 8 weeks
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Carmen Research
Atlanta, Georgia
Midwest Clinical Research Center
Dayton, Ohio
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.